Skip to main content
Market intelligence
LXEOHealthcare

Lexeo Therapeutics Inc. insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 18, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 18, 2026Louis Edward TamayoChief Financial OfficerSale4,117$4.91$20,203
Aug 18, 2026Jose Manuel OteroChief Operating OfficerSale1,304$4.96$6,464
Aug 18, 2026Richard Nolan TownsendChief Executive OfficerSale3,345$4.95$16,562